5AM PARTNERS VII, LLC sold 148.08K shares of SKYE BIOSCIENCE, INC. on the open market
Open‑market sale worth $239.6K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 9/24/2026ACC: 0001231919-26-001224
10% Owner
Since Aug 2023
-148.08K
Net shares
Net seller
$239.6K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
148.08K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−27.61K
Price / share
$1.65
Trade value
$45.56K
% of position
19.4%
9/22/2026
142.46K→114.85K
Common Stock
Indirect
Shares
−1.09K
Price / share
$1.65
Trade value
$1.80K
% of position
19.4%
9/22/2026
5.62K→4.53K
Common Stock
Indirect
Shares
−114.85K
Price / share
$1.61
Trade value
$184.91K
% of position
New position
9/23/2026
114.85K→0.00
Common Stock
Indirect
Shares
−4.53K
Price / share
$1.61
Trade value
$7.29K
% of position
New position
9/23/2026
4.53K→0.00
Total
Net shares
−148.08K
Net value
-$239.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/22/2026 | S · Sale | −27.61K | $1.65 | $45.56K | 19.4% | 142.46K | 114.85K |
| Common Stock Indirect | 9/22/2026 | S · Sale | −1.09K | $1.65 | $1.80K | 19.4% | 5.62K | 4.53K |
| Common Stock Indirect | 9/23/2026 | S · Sale | −114.85K | $1.61 | $184.91K | New position | 114.85K | 0.00 |
| Common Stock Indirect | 9/23/2026 | S · Sale | −4.53K | $1.61 | $7.29K | New position | 4.53K | 0.00 |
| Total | −148.08K | -$239.56K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned981.27K
Total
981.27K indirect981.27K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 981.27K | Indirect |
| Total | 981.27K | 981.27K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported